Skin Grafting in Pyoderma Gangrenosum Skin Grafting in Pyoderma Gangrenosum
This case of an allograft performed on a patient with pyoderma gangrenosum illustrates another option for this difficult-to-treat condition.ePlasty, Open Access Journal of Plastic Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2018 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

Noninvasive Imaging Could Help Diagnose Rejection in Lung Recipients Noninvasive Imaging Could Help Diagnose Rejection in Lung Recipients
Probe-based confocal laser endomicroscopy (pCLE) could help identify acute cellular rejection (ACR) in lung allografts, a preliminary study suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 5, 2018 Category: Radiology Tags: Transplantation News Source Type: news

Medical News Today: What to know about bone grafts
Doctors use bone grafts in the treatment of a variety of health issues, including fractures, bone infections, spinal fusions, tumors, and joint problems. In this article, learn about the different types of bone grafts and replacement materials. We also cover the possible risks, complications, and the recovery process. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2018 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

Failing Implant #14: Thoughts on Treatment Plans?
This patient had a crestal sinus bone graft and implant placed in #14 site about 5 years.   The patient does not have any symptoms, but the radiographic images show implant failure.The postFailing Implant #14: Thoughts on Treatment Plans? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 29, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news

Avita Medical touts publication of pivotal ReCell trial data
Avita Medical (ASX:AVH) today released results from a pivotal clinical trial of its ReCell autologous cell harvesting device in treating deep partial-thickness second-degree burns. The ReCell autologous cell harvesting device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, Avita said. Results from the trial were published in the Journal of Burn Care & Research, the Melbourne and Valencia, Calif.-based company said. Data from the 101-patient study indicated that burn sites treated with the ReCell device required 9...
Source: Mass Device - June 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Regenerative Medicine avitamedical Source Type: news

Can placental tissue implants limit back and leg pain?
Regenerative technology company StimLabs has enrolled the first patient in a clinical trial using shelf-stable placental tissue to reduce complications following herniated disc surgery. The multi-center, randomized controlled trial will evaluate the safety and efficacy of Revita, StimLabs’ full-thickness placental allograft, which surgeons will place following lumbar microdiscectomy procedures. Microdiscectomy is a common, minimally invasive procedure to remove the herniated or protruding portion of the intervertebral disc that is compressing the traversing spinal nerve root. Common post-surgical complicati...
Source: Mass Device - June 26, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Neurological Surgical StimLabs Source Type: news

7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation th...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news

Wright Medical raises $675m in private placement
Wright Medical (NSDQ:WMGI) said today it inked a deal for $675 million in debt to be offered by a wholly-owned subsidiary. The Amsterdam-based company is offering 1.625% convertible senior notes due 2023 in the offering, which was arranged between Wright, a subsidiary and both investors and institutional buyers, according to an SEC filing. Wright Medical said that it expects the notes will be issued on June 28. Along with the offering, Wright Medical said it inked a deal with holders of its 2% cash convertible senior notes due 2020 to exchange approximately $401 million in existing notes for $460 million in the newly ...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat wrightmedical Source Type: news

Bone graft in preparation for implants: recommendations?
I have a 51 year old healthy female referred for grafting to allow implants in areas #26 and #27. Thoughts on this case?The postBone graft in preparation for implants: recommendations? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 19, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Source Type: news

Outcomes in Renal Allografts With Deceased Donors Outcomes in Renal Allografts With Deceased Donors
What does this study tell us about the effects of HLA matching on the outcomes of deceased-donor kidney allografts?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2018 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

New, printable and flexible ceramic bone grafts could be a game changer
"Hyperelastic Bone" can be matched to patients or used off-the-shelf and could be cheaper, better and less painful than conventional bone tissue Full story at https://www.nsf.gov/news/special_reports/science_nation/printedbonegrafts.jsp?WT.mc_id=USNSF_51 This is an NSF News item. (Source: NSF News)
Source: NSF News - June 18, 2018 Category: Science Source Type: news

Osteochondral Allograft Effective in Some Knee Cartilage Repair
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - June 15, 2018 Category: Orthopaedics Tags: Snapshot Source Type: news

Pediatric Kidney Recipients Often Have Subclinical Inflammation
FRIDAY, June 15, 2018 -- For pediatric kidney recipients, subclinical inflammation is associated with increased risk for acute rejection and allograft failure, according to a study published online May 15 in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2018 Category: Pharmaceuticals Source Type: news

Wright Medical wins FDA PMA for Augment injectable bone graft
Wright Medical (NSDQ:WMGI) said today it won FDA premarket approval for its Augment injectable bone graft. The bone graft won clearance for the same indications as the Amsterdam-based company’s non-injectable Augment bone graft. The newly cleared Augment Injectable consists of both recombinant human platelet derived growth factor and a blend of Type I collagen and beta tri-calcium phosphate, the company said. “In Canada, my colleagues and I have been using Augment Injectable since 2011 based upon its ideal handling characteristics and impressive clinical results.  FDA approval of Augmen...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Orthopedics Pre-Market Approval (PMA) Regulatory/Compliance wrightmedical Source Type: news

NuVasive launches AttraX scaffold bone graft biologic
NuVasive (NSDQ:NUVA) said today it launched its AttraX scaffold ceramic-collagen bone graft in the US, touting that the scaffold’s surface has been shown to increase bone formation for faster fusion than standard ceramic bone grafts. The San Diego-based company claims that the Attrax scaffold features a unique microstructure and microporosity that are optimized for bone formation, and that its AttraX surface technology drives the differentiation of mesenchymal stem cells into bone-forming osteoblasts without the need for added growth factors. “AttraX scaffold was easy to use and maintained excellent handli...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Spinal Nuvasive Source Type: news

MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
MARIETTA, Ga., June 7, 2018 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that John D. Harris has joined the Company as its Senio... Biopharmaceuticals, Regenerative Medicine, Personnel MiMedx Group, PURION, placental tissue, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

Camber Spine wins FDA nod for combining existing tech
Camber Spine Technologies has won 510(k) clearance from the FDA to market its ENZA-A Titanium Anterior Lumbar Interbody Fusion (ALIF) system, which leverages two of its existing technologies. The new device borrows from the Wayne, Penn.-based company’s first-generation ENZA, which has dual-grip anchor technology, and from its Spira line, which use spiral support arches to increase fusion rates and stabilization. The FDA approved the original Spira device in August 2017. ENZA-A is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2 to S1 and i...
Source: Mass Device - June 4, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Spinal camberspine Source Type: news

7 medtech stories we missed this week: May 25, 2018
[Image from unsplash.com]From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance for its Celivizio 100 series F400 and F800 with new Confocal Miniprobe, the CranioFlex. The clearance allows the device to be used during neurosurgical procedures. The Cellvizio 100 with CranioFlex gives allows for imaging of tissue internal microstructures a...
Source: Mass Device - May 25, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Imaging Implants Patient Monitoring Regulatory/Compliance Bonesupport collagenmatrix crossroadsextremitysystems Implanet Mauna Kea Technologies MC10 Medacta xablec Source Type: news

How Orthopedics Innovation Doesn ’t Get Lost In Shuffle
What are some of the growing trends and unmet needs in the orthopedics market? If you’re a surgeon, just how do you convince the CEO of a hospital to invest in these technologies? During MDM East, held in New York from June 12-14,  Michael Levy, MD will be a part of two panels that will touch on some of these subjects. The panels are titled “Prominent Physicians Address Unmet Needs in Orthopedics” and “Selling Your Idea to Upper Management.” Levy is an expert in the field and has been involved in orthopedics for 34 years including basic research, orthopedic product development, and c...
Source: MDDI - May 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Orthopedics Source Type: news

FDA clears Zimmer Biomet ’ s 3D-printed titanium Zyston spinal implant
Zimmer Biomet (NYSE:ZBH) said yesterday it won FDA 510(k) clearance for its Zyston Strut open titanium interbody spacer system, touting it as the company’s first 3D-printed titanium spinal implant. The Zyston Strut open titanium system is a family of lumbar cages intended to enhance strength, graft capacity and visualization capabilities of interbody spacers in spinal fusion cases, the Warsaw, Ind.-based company said. The system also includes surgical instruments needed for insertion, manipulation and removal. The newly cleared cages will be available in a series of sizes to accommodate different patient anatomi...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Spinal zimmerbiomet Source Type: news

Therapies After Autograft Failure in a Patient With Melanoma Therapies After Autograft Failure in a Patient With Melanoma
This report describes a case of amelanotic melanoma of the foot initially diagnosed and treated as a pressure ulcer.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Does anterior cruciate ligament reconstruction affect the outcome of osteochondral allograft transplantation? A matched cohort study with a mean follow-up of 6 years - T írico LEP, McCauley JC, Pulido PA, Bugbee WD.
BACKGROUND: Few studies have evaluated the influence of anterior cruciate ligament (ACL) reconstruction on the outcome of cartilage repair. Hypothesis/Purpose: The purpose was to investigate the association between ACL reconstruction and functional outcome... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Medtronic wins expanded indications for Infuse bone growth protein
Medtronic (NYSE:MDT) said today it won expanded approval from the FDA for its Infuse bone growth protein implant, marking the second expansion for the implant over the past two years. The Infuse implant contains the active ingredient rhBMP-2, a manufactured version of a bone growth protein normally present in the body. The Infuse device is designed for use with certain Medtronic interbody fusion devices to treat lumbar degenerative disc disease. “Different spine patients can have very different surgical needs, so the more options surgeons have to combine a clinically-proven bone grafting technology like Infuse with d...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Spinal Medtronic Source Type: news

Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
Collagen Technology Mimics Nature, to Regenerate Bone and Cartilage NESS ZIONA, Israel, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will foc... Devices, Orthopaedic, Regenerative Medicine Datum Biotech, Datum Orthobiologics, bone graft, GLYMATRIX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Infected tooth with sinus perforation treatment: feedback?
A middle aged woman presented with a swollen gingiva buccal to tooth #15 which had a previous RCT and crown. I am wondering if I should place a membrane and bone graft after extracting the tooth or if I should let it drain on its own?The postInfected tooth with sinus perforation treatment: feedback? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 17, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Surgical Source Type: news

Spineology touts 1-year OptiMesh lumbar interbody fusion study results
Spinal tech developer Spineology today released 12-month results from a study of its OptiMesh deployable implant designed for use in instrumented lumbar interbody fusion procedures to treat degenerative disc disease. Results from the Scout trial were presented at the annual meeting of the International Society for the Advancement of Spine Surgery in Toronto, the St. Paul, Minn.-based company said. “We are grateful to Dr. Chi and all the Scout investigators for their dedication in helping us to complete this important clinical trial. We look forward to completing the patient follow-up and gaining the market ...
Source: Mass Device - April 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Spinal Spineology Source Type: news

Sinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve?
After 5 months of uneventful healing of implants, I now see a small lesion resembling a sinus tract that is present in the immediate vicinity of one tenting screw.The postSinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 11, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

Ridge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft?
Any thoughts on using synthetic bone augmentation materials, like Bond Apatite for lateral ridge augmentation or ridge widening?The postRidge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 6, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news

7 medtech stories we missed this week: March 23, 2018
[Image from unsplash.com]From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource Medizone announced in a March 22 press release that it has signed a product evaluation agreement with Innovasource. As part of the agreement, Innovasource will be leading the evaluation of the AsepticSure system and compare it to existing cleaning practices in a number of facilities and settings. AsepticSure is desig...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Food & Drug Administration (FDA) Hospital Care Imaging Implants Patient Monitoring Regulatory/Compliance Respiratory advantismedicalimaging aziyobiologics Balt endospan Medizone MedTech Olympus Respiratory Motion Source Type: news

LifeNet Health launches unique, life-saving vascular allograft
AngioGraft® Aortoiliac Artery, the first to offer pressurized sizing, offers unparalleled efficiency and precision in aortic reconstruction VIRGINIA BEACH, Va., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- LifeNet Health today announc... Devices, Cardiology, Surgery, Product Launch LifeNet Health, AngioGraft, Aortoiliac Artery, vascular allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Cerapedics wins FDA IDE nod for P-15L bone graft trial
Cerapedics said today it won FDA investigational device exemption approval to launch a clinical trial examining the safety and efficacy of its P-15L Peptide Enhanced bone graft. In the trial, the Wesminster, Colo.-based company will explore the use of the P-15L graft as it compares to autografts in transforaminal lumbar interbody fusion procedures meant for treating degenerative disk disease. “Prior research of this proprietary P-15 technology has demonstrated potential benefits in fusion rates, neurological outcomes and safety in cervical and lumbar fusions. We are pleased to participate in a new study evaluati...
Source: Mass Device - March 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Spinal Cerapedics Inc. Source Type: news

Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
Pivotal study to evaluate next-generation synthetic small peptide technology (P-15) compared to autograft in most common spine procedure WESTMINSTER, Colo., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthob... Devices, Orthopaedic, FDA Cerapedics, orthobiologic, i-FACTOR, Peptide Enhanced Bone Graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Autogenous Bone: Most Effective Material?
Two recent studies show good results with autogenous bone grafts, long considered the most effective material in bone regeneration procedures.The postAutogenous Bone: Most Effective Material? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - March 13, 2018 Category: Dentistry Authors: osseonews Tags: Implant News Surgical Source Type: news

Osteochondral allograft transplantation effective for certain knee cartilage repairs
(American Orthopaedic Society for Sports Medicine) Isolated femoral condyle lesions account for 75 percent of the cartilage repair procedures performed in the knee joint, and physicians have a variety of techniques to consider as part of surgical treatment. Osteochondral allograft transplantation (OCA) is a valuable and successful approach for this condition, as described by research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 10, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic wins one lawsuit, settles state AG probes over Infuse
Medtronic (NYSE:MDT) said a shareholder lawsuit brought over its Infuse bone-growth protein is over, after the U.S. Supreme Court declined to review the case. Approved in 2002 for use in spinal fusion surgery, Infuse at one point had annual sales of nearly $1 billion. The bone-grafting product has since been linked to abnormal bone growth, certain cancers and male reproductive problems. Fridley, Minn.-based Medtronic has been accused of not only downplaying the product’s risks but also promoting it for off-label use. The derivative lawsuit, brought in March 2012 by  investor Charlotte Kokocinski in the U.S. Dist...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Orthopedics Regenerative Medicine Medtronic Source Type: news

Human bone tissue grown from a patient's fat cells in a lab, then implanted to finish growing inside the patient's body
(Natural News) Thanks to an extraordinary medical procedure, a man is on the road to recovering from a fractured tibia with a bone graft created from his own fat cells. This isn’t a work of science fiction; it’s the result of efforts made by Bonus BioGroup, an Israel-based biomedical company. According to the TimesOfIsrael.com, a... (Source: NaturalNews.com)
Source: NaturalNews.com - March 4, 2018 Category: Consumer Health News Source Type: news

Collaboration Is Key in Bioventus ’s Path Toward Innovation
Durham, NC-based Bioventus is hoping to expand its position in the allograft market through a collaboration with LifeLink Foundation. The accord will have the companies work together to co-develop a next-generation bone allograft solution for use in spine and trauma surgery. Bivoentus specializes in orthobiologic products for bone healing, bone graft, and knee osteoarthritis. “LifeLink is a fully equipped tissue bank,” Samson Tom, vice president of research and development at Bioventus, told MD+DI. “Here at Bioventus, we have significant infrastructure, but we are not a tissue bank. We recognize partneri...
Source: MDDI - February 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Purulent discharge and radiolucent area around implant: Advice?
I placed an implant at area 32 with bone graft.  Saw patient after 18 days and there is purulent discharge and a radiolucent area around the implant.  (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - February 19, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news

Distal tibial allograft reconstruction and Latarjet may offer similar outcomes for recurrent anterior shoulder instability
According to a study published online in The American Journal of Sports Medicine, fresh distal tibia allograft (DTA) reconstruction and the Latarjet procedure may offer similar outcomes for recurrent anterior shoulder instability.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - February 10, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Detecting and treating dnDSA early preserves allograft function
(Children's National Health System) Monitoring and treating de novo donor-specific antibodies before they could cause graft damage helped to decrease dnDSA in a majority of pediatric kidney transplant recipients at Children National Health System and prevented graft failure in the first few years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2018 Category: International Medicine & Public Health Source Type: news

Finland ’ s BBS-Bioactive Bone Substitute plans $10m IPO
BBS-Bioactive Bone Substitutes said today that’s its planning for an initial public offering later this year it hopes will bring in some $10 million. Oulu, Finland-based BBS said it plans to list 1.5 million shares at €5.50 apiece beginning Feb. 5 for gross proceeds of €7.7 million, or roughly $9.6 million. The shares, due to trade on the First North Finland and NASDAQ First North Sweden exchanges, would represent about 23.9% of BBS’s total shares if the flotation is fully subscribed. Based on proteins extracted from reindeer bone, BBS’s Artebone is designed to be injected to the site ...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Orthopedics Regenerative Medicine Wall Street Beat bioactivebonesolutions Source Type: news

Socket grafting after extraction of an infected endodontic tooth?
How do you treat and clean the socket after extraction of an infected endodontic tooth and prepare it for the bone graft for ridge preservation? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 30, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Clinical Questions Source Type: news

The University City Science Center is backing development of NJIT's novel bone graft tech
(New Jersey Institute of Technology) Treena Arinzeh, director of NJIT's Tissue Engineering and Applied Biomaterials Laboratory, has been awarded a grant from the University City Science Center in Philadelphia to help commercialize technology she is developing to reduce the recovery time and cost associated with bone grafts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

West Sacramento-based bone graft company raises funds, wins federal clearance
Molecular Matrix Inc. has raised money and passed a major regulatory milestone for its product that helps bone heal. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 19, 2018 Category: Health Management Authors: Mark Anderson Source Type: news

West Sacramento-based bone graft company raises funds, wins federal clearance
Molecular Matrix Inc. has raised money and passed a major regulatory milestone for its product that helps bone heal. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 19, 2018 Category: Biotechnology Authors: Mark Anderson Source Type: news

New Kleiner Spine Graft Delivery Tool Improves Outcomes for Patients, Surgeons, Hospitals and Payers
DENVER, Jan. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Kleiner Device Labs today announced full commercial availability of a new spinal bone graft delivery tool, the KG® 1, featuring a patented design that facilitates less-invasive procedu... Devices, Oncology, Neurosurgery, Product Launch Kleiner Device Labs, bone graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news

Do I have to place a membrane in this immediate implant case?
I placed an implant in the maxillary lateral incisor site immediately after extraction and did a small particulate bone graft. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 5, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

RTI Surgical buys Zyga Tech and its SImmetry sacroiliac fusion device, updates 2018 outlook
RTI Surgical (NSDQ:RTIX) yesterday announced an agreement to purchase Zyga Technology and its SImmetry sacroiliac joint fusion system and today released updated guidance for 2018 and beyond. The Alachua, Fla.-based RTI surgical said that Zyga Technology has approximately 30 employees and $4 million in annual revenue, and that it plans to fund the acquisition through a combination of cash and through borrowing under its existing credit facility. Terms of the deal were not disclosed, and RTI Surgical it expects the deal to close when the Delaware Department of State re-opens as it is currently closed due to incleme...
Source: Mass Device - January 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Spinal RTI Surgical Source Type: news

NuVasive wins expanded FDA nod, launches interbody fusion devices
NuVasive Inc. (NSDQ:NUVA) said today it won expanded FDA 510(k) clearance for its Cohere cervical interbody fusion device and that it launched the Coalesce thoracolumbar interbody fusion device. Both the launch and updated clearance comes from the company’s acquisition of Vertera Spine, which it closed last September. The Cohere and Coalesce implants use porous version of the material polyetheretherketone, or PEEK, and are designed to provide three-dimensional achitecture to elicit and encourage bone growth, San Diego, Calif.-based NuVasive said. “Our strategy in building our AMS portfolio is to ...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) Regulatory/Compliance Spinal Nuvasive Source Type: news

Distants between implants considerable: long-term success?
I placed 2 implants in the maxillary right posterior quadrant using an indirect sinus lift without bone grafts.  I am concerned about a few issues. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 2, 2018 Category: Dentistry Authors: gkaplowitz Tags: Clinical Cases Surgical Source Type: news